S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item

Inhibrx (INBX) Earnings Date, Estimates & Call Transcripts

$34.98
-0.04 (-0.11%)
(As of 04/12/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 13Estimated
Actual EPS
(Feb. 28)
-$1.73 Missed By -$0.66
Consensus EPS
(Feb. 28)
-$1.07
Skip Charts & View Estimated and Actual Earnings Data

INBX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INBX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Inhibrx Analyst EPS Estimates

Current Year EPS Consensus Estimate:($4.34) EPS

INBX Earnings Date and Information

Inhibrx last released its quarterly earnings results on February 28th, 2024. The reported ($1.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.07) by $0.66. The firm had revenue of $1.63 million for the quarter, compared to analysts' expectations of $0.10 million. Inhibrx has generated ($5.03) earnings per share over the last year (($5.03) diluted earnings per share). Inhibrx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

Inhibrx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)
------- 
2/28/2024Q4 2023($1.07)($1.73)($0.66)($1.73)$0.10 million$1.63 million
11/9/2023Q3 2023($1.01)($1.10)($0.09)($1.10)-$0.12 million
8/7/2023Q2 2023($1.02)($1.08)($0.06)($1.08)-$0.03 million
5/8/2023Q1 2023($0.84)($1.12)($0.28)($1.12)$0.30 million$0.02 million
3/6/2023Q4 2022($0.80)($0.95)($0.15)($0.95)$0.30 million$0.27 million
11/7/2022Q3 2022($1.01)($0.90)+$0.11($0.90)$0.70 million$0.28 million
8/8/2022Q2 2022($0.84)($0.97)($0.13)($0.97)$0.90 million$0.71 million
5/9/2022Q1 2022($0.62)($0.80)($0.18)($0.80)$1.00 million$0.93 million
2/28/2022Q4 2021($0.53)($0.55)($0.02)($0.55)$2.50 million$2.86 million
11/9/2021Q3 2021($0.60)($0.54)+$0.06($0.54)$1.00 million$2.53 million
8/9/2021Q2 2021($0.56)($0.55)+$0.01($0.55)$0.90 million$0.95 million
5/13/2021Q1 2021($0.61)($0.51)+$0.10($0.51)$1.10 million$0.89 million

Inhibrx Earnings - Frequently Asked Questions

When is Inhibrx's earnings date?

Inhibrx has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on INBX's earnings history.

Did Inhibrx beat their earnings estimates last quarter?

In the previous quarter, Inhibrx (NASDAQ:INBX) missed the analysts' consensus estimate of ($1.07) by $0.66 with a reported earnings per share (EPS) of ($1.73). Learn more on analysts' earnings estimate vs. INBX's actual earnings.

How much revenue does Inhibrx generate each year?

Inhibrx (NASDAQ:INBX) has a recorded annual revenue of $1.80 million.

How much profit does Inhibrx generate each year?

Inhibrx (NASDAQ:INBX) has a recorded net income of -$241.36 million. INBX has generated -$5.03 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:INBX) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners